Forkhead box N (FOXN) Inhibitors
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ON-01910 | 1225497-78-8 | sc-364556 sc-364556A | 5 mg 10 mg | $300.00 $700.00 | ||
Although not a direct inhibitor of FOX proteins, rigosertib has been observed to downregulate Forkhead Box expression. | ||||||
Bithionol | 97-18-7 | sc-239383 | 25 g | $79.00 | ||
This compound has been repurposed as a Forkhead Box inhibitor. It disrupts the Forkhead Box signaling pathway, impacting cell proliferation and survival | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Cyclopamine inhibits the Hedgehog signaling pathway, which could modulate the differentiation pathways in thymic epithelial cells where FOXN is critical. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA is a histone deacetylase inhibitor. It alters chromatin structure and gene expression, which can indirectly modulate FOXN expression and its downstream effects. | ||||||
Artemisinin | 63968-64-9 | sc-202960 sc-202960A | 100 mg 1 g | $45.00 $252.00 | 1 | |
Artemisinin has been shown to downregulate Forkhead Box expression, thereby inhibiting growth and proliferation. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646 is a selective p300/CPB histone acetyltransferase inhibitor, possibly affecting the acetylation and thereby the expression levels of FOXN. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor, thereby potentially downregulating AKT signaling and affecting pathways that could modulate FOXN activity. | ||||||
Bicalutamide | 90357-06-5 | sc-202976 sc-202976A | 100 mg 500 mg | $42.00 $146.00 | 27 | |
Bicalutamide is an androgen receptor antagonist. It may indirectly modulate hormonal regulation pathways that influence FOXN expression in thymic epithelial cells. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
CHIR99021 is a GSK-3 inhibitor which can modulate Wnt signaling, potentially altering cellular processes and signaling pathways that could affect FOXN activity. | ||||||
MLN8237 | 1028486-01-2 | sc-394162 | 5 mg | $220.00 | ||
Alisertib is an Aurora kinase A inhibitor. By altering cell cycle progression, it could affect the cellular context of thymic epithelial cells impacting FOXN. | ||||||